EPS for Spire (SR) Expected At $0.40; Advaxis, Inc. (ADXS) Had 4 Analysts Last Week

July 19, 2017 - By Linda Rogers

Analysts expect Spire Inc (NYSE:SR) to report $0.40 EPS on August, 2.They anticipate $0.07 EPS change or 21.21% from last quarter’s $0.33 EPS. SR’s profit would be $19.41 million giving it 43.91 P/E if the $0.40 EPS is correct. After having $2.38 EPS previously, Spire Inc’s analysts see -83.19% EPS growth. About 104,631 shares traded. Spire Inc (NYSE:SR) has risen 11.86% since July 19, 2016 and is uptrending. It has underperformed by 4.84% the S&P500.

Among 4 analysts covering Advaxis (NASDAQ:ADXS), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Advaxis had 6 analyst reports since September 11, 2015 according to SRatingsIntel. The rating was initiated by Guggenheim with “Buy” on Friday, September 11. Barclays Capital initiated the shares of ADXS in report on Tuesday, September 22 with “Overweight” rating. The rating was maintained by Cantor Fitzgerald on Monday, June 12 with “Buy”. H.C. Wainwright maintained it with “Buy” rating and $2300 target in Wednesday, June 14 report. The company was maintained on Wednesday, May 31 by Cantor Fitzgerald. Cantor Fitzgerald maintained the shares of ADXS in report on Thursday, July 6 with “Buy” rating. See Advaxis, Inc. (NASDAQ:ADXS) latest ratings:

06/07/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $19.0000 Maintain
14/06/2017 Broker: H.C. Wainwright Rating: Buy New Target: $23.0000 Maintain
12/06/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $19.0000 Maintain
31/05/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $19.0000 Maintain

Among 3 analysts covering Spire (NYSE:SR), 0 have Buy rating, 0 Sell and 3 Hold. Therefore 0 are positive. Spire had 3 analyst reports since August 19, 2016 according to SRatingsIntel. The firm earned “Neutral” rating on Friday, August 19 by Ladenburg Thalmann. The rating was downgraded by Wells Fargo to “Market Perform” on Tuesday, September 6. As per Wednesday, January 25, the company rating was initiated by Credit Suisse.

Spire Inc., formerly The Laclede Group, Inc., is engaged to transform its business and pursue growth by growing its gas utility business through prudent investment in infrastructure upgrades and organic growth initiatives; acquire and integrate gas utilities; modernize its gas assets, and invest in innovation. The company has market cap of $3.41 billion. The Firm has two business divisions, which include gas utility and gas marketing. It has a 21.49 P/E ratio. The gas utility segment includes the regulated activities of Laclede Gas Company , Alabama Gas Corporation (Alagasco) and EnergySouth, Inc. (EnergySouth).

About 379,705 shares traded. Advaxis, Inc. (NASDAQ:ADXS) has risen 11.01% since July 19, 2016 and is uptrending. It has underperformed by 5.69% the S&P500.

Advaxis, Inc. is a clinical-stage biotechnology firm focused on the discovery, development and commercialization of Listeria monocytogenes -Listeriolysin O (LLO) cancer immunotherapies. The company has market cap of $298.89 million. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. It currently has negative earnings. These Lm-LLO strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors.